| Catalog No. | HY057096 |
| Brand | abinScience |
| Host species | Human |
| Species reactivity | Human |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4. |
| Purity | >95% as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG |
| Applications | ELISA, Bioactivity: FCM, Functional assay, Research in vivo |
| Target | CD3E, CD3e, T-cell surface antigen T3/Leu-4 epsilon chain, T-cell surface glycoprotein CD3 epsilon chain, T3E |
| References | 1. Hinojosa LE, et al. Construction of a recombinant non-mitogenic anti-human CD3 antibody. Hybridoma (Larchmt). 2010;29(2):115-124. [HY057096] 2. Suarez Pestana E, et al. Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s). Br J Cancer. 1997;75(2):213-220. [HY057096] |
| Purification | Protein A/G purified from cell culture supernatant. |
| Biological activity | IOR-T3 (1 h) potently binds to CD3 on human PBMCs, with equivalent antigen-binding capacity to its chimeric variants T3q and T3q(Ala=Ala) [1]. IOR-T3 (70-100 ug/mL; 7 days) does not inhibit the growth of human non-small-cell lung carcinoma H125 cells when used at 100 ug/mL for 7 days [2]. Cell Proliferation Assay [2] Cell Line: human non-small-cell lung carcinoma H125 cells Concentration: 70, 90, 100 ug/mL Incubation Time: 7 days Result: Showed no inhibitory effect on H125 cell growth, with cell protein content remaining at 100% of control levels. |
| Endotoxin level | < 10 EU/mg as determined by LAL method. |
| Accession | P07766 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternative name | IOR-T3, IORT3, IORT3 |
| Clone ID | IOR-T3 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
